The Global Health and Emerging Pathogens Institute

The Global Health and Emerging Pathogens Institute is expanding the translational aspects of Mount Sinai's antimicrobial research by creating programs in vaccine, antiviral, and antimicrobial drug development.

The Institute, based in New York City, builds on Mount Sinai’s internationally recognized expertise in RNA virus research and encompasses ongoing research on the molecular pathogenesis of influenza, HIV, and dengue and Ebola viruses, as well as on hepatitis C.  Read More

Meet the Director

Adolfo García-Sastre, PhD, Professor of Microbiology, is Co-Director of the Global Health and Emerging Pathogens Institute and Principal Investigator for the Center for Research on Influenza Pathogenesis, an NIAID Center of Excellence for Influenza Research and Surveillance.  Read More